Category: Press Release

Scopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Release of Preclinical Data Being Presented at 17th Annual Meeting of the Oligonucleotide Therapeutics Society

Scopus BioPharma Announces Adjournment of Annual Meeting of Stockholders

Scopus BioPharma Announces Adjournment of Annual Meeting of Stockholders

Scopus BioPharma Announces $9.75 Million Private Placement Priced At-The-Market

Scopus BioPharma Sends Letter Urging Stockholders to Vote “FOR ALL” of the Company’s Director Nominees on the WHITE Proxy Card

Scopus BioPharma Issues Open Letter to Stockholders Detailing Morris Laster’s Campaign Against the Company